EP4716691A2 - Onkolytische peptide - Google Patents

Onkolytische peptide

Info

Publication number
EP4716691A2
EP4716691A2 EP24811920.8A EP24811920A EP4716691A2 EP 4716691 A2 EP4716691 A2 EP 4716691A2 EP 24811920 A EP24811920 A EP 24811920A EP 4716691 A2 EP4716691 A2 EP 4716691A2
Authority
EP
European Patent Office
Prior art keywords
peptide
seq
jhu
cancer
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP24811920.8A
Other languages
English (en)
French (fr)
Inventor
Natsuki FURUKAWA
Aleksander S. Popel
Niranjan B. Pandey
Adam MIRANDO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johns Hopkins University
Original Assignee
Johns Hopkins University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johns Hopkins University filed Critical Johns Hopkins University
Publication of EP4716691A2 publication Critical patent/EP4716691A2/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
EP24811920.8A 2023-05-23 2024-05-23 Onkolytische peptide Pending EP4716691A2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202363503800P 2023-05-23 2023-05-23
US202463551745P 2024-02-09 2024-02-09
PCT/US2024/030812 WO2024243427A2 (en) 2023-05-23 2024-05-23 Oncolytic peptides

Publications (1)

Publication Number Publication Date
EP4716691A2 true EP4716691A2 (de) 2026-04-01

Family

ID=93590465

Family Applications (1)

Application Number Title Priority Date Filing Date
EP24811920.8A Pending EP4716691A2 (de) 2023-05-23 2024-05-23 Onkolytische peptide

Country Status (3)

Country Link
EP (1) EP4716691A2 (de)
CN (1) CN121175330A (de)
WO (1) WO2024243427A2 (de)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2015781A4 (de) * 2005-09-12 2009-12-23 Univ Johns Hopkins Zusammensetzungen mit antiangiogener wirkung und ihre verwendungen
US9415069B2 (en) * 2012-06-04 2016-08-16 National Health Research Institutes Immunosuppressive cells and methods of making and using thereof
US20230116760A1 (en) * 2019-12-16 2023-04-13 Dana-Farber Cancer Institute, Inc. Structurally-stabilized oncolytic peptides and uses thereof

Also Published As

Publication number Publication date
WO2024243427A3 (en) 2025-04-17
CN121175330A (zh) 2025-12-19
WO2024243427A2 (en) 2024-11-28

Similar Documents

Publication Publication Date Title
EP2650008B1 (de) Verwendung von zelldurchlässigen Peptidhemmern des JNK-Signaltransduktionsweges zur Behandlung verschiedener Krebs-Erkrankungen
KR102314231B1 (ko) 전립선 암 치료용 조성물
AU2014346051B2 (en) Use of IL-22 dimers in manufacture of medicaments for treating pancreatitis
EP2552470B1 (de) Peptide zur angiogeneseförderung und verwendung davon
CN1816564B (zh) 能选择性杀伤癌细胞的RasGAP衍生肽
US20090227521A1 (en) Use of compounds in the treatment of ischemia and neurodegeneration
US20140288006A1 (en) Ptd-smad7 therapeutics
JP7069126B2 (ja) 化学療法誘発性末梢性ニューロパシーおよび難聴を処置または予防するためのｂｃｌ－ｗポリペプチドおよび模倣物
WO2024243427A2 (en) Oncolytic peptides
CN106222155A (zh) 一种多肽及其在制备结肠炎及结肠炎相关结直肠癌药物中的应用
KR20220142954A (ko) 세포 투과 펩티드, 항암 펩티드 및 이를 포함하는 암 예방 또는 치료용 약학적 조성물
TWI337184B (en) Apoptosis-inducing polypeptides
US10046022B2 (en) Synthetic peptide that increases radiosensitivity of tumor cells and use of same
CN102776264B (zh) 与凋亡或坏死相关的TNFα短肽及其应用
EP1448593B1 (de) Alpha-fetoproteinpeptide und deren verwendungen
WO2003080103A1 (en) Antagonists of megalin or cubilin for use in preventing organ damage induced by therapeutic agents
US20110269692A1 (en) Alpha-fetoprotein peptides and uses thereof
CN108619488B (zh) 一种治疗肿瘤的联合用药方法
US9408888B2 (en) High affinity bivalent helically constrained peptide against cancer
KR102846910B1 (ko) 항암 활성을 갖는 신규한 펩타이드 및 이의 용도
US20250170212A1 (en) Compositions and methods of treating amyotrophic lateral sclerosis (als) and related disorders
US20230203107A1 (en) Peptide for treating sepsis derived from rv3364c protein of mycobacterium tuberculosis
WO2022232567A2 (en) Cyclic peptide inhibitors of usp22
WO2025104358A1 (es) Uso de proteínas conglutinas beta como agentes radiosensibilizadores
HK1223556B (zh) Il-22二聚体在制备用於治疗胰腺炎的药物中的用途

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20251124

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR